These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 7293434)
1. [Prospects for genetic studies of cancer of the gastrointestinal tract]. Klimenkov AA; Sel'chuk VIu; Chudina AP Vestn Akad Med Nauk SSSR; 1981; (7):49-52. PubMed ID: 7293434 [No Abstract] [Full Text] [Related]
2. [The importance of a genetic factor in cancers of the digestive tract: hereditary cancer predispositio]. Dubarry JJ Minerva Med; 1968 Oct; 59(79):4143-4. PubMed ID: 5684450 [No Abstract] [Full Text] [Related]
3. Gene therapy for gastrointestinal tract cancer: a review. Heideman DA; Gerritsen WR; Craanen ME Scand J Gastroenterol Suppl; 2000; (232):93-100. PubMed ID: 11232500 [TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to gastrointestinal cancer: minireview of the genomewide studies. Tokuoka M; Ishii H; Mimori K; Inoue H; Doki Y; Mori M Ann Surg Oncol; 2009 Jul; 16(7):1783-8. PubMed ID: 19437079 [TBL] [Abstract][Full Text] [Related]
5. Telomere dysfunction and DNA damage checkpoints in diseases and cancer of the gastrointestinal tract. Rudolph KL; Hartmann D; Opitz OG Gastroenterology; 2009 Sep; 137(3):754-62. PubMed ID: 19619548 [No Abstract] [Full Text] [Related]
6. [Cytogenetic and medical genetic research on families with a high predisposition for the development of cancer of the gastrointestinal tract]. Monakhov AS; Guliaev AV Vopr Onkol; 1993; 39(4-6):184-8. PubMed ID: 7975393 [TBL] [Abstract][Full Text] [Related]
7. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Macarthur M; Hold GL; El-Omar EM Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G515-20. PubMed ID: 15010360 [TBL] [Abstract][Full Text] [Related]
8. Homeobox genes and their functions on development and neoplasm in gastrointestinal tract. Yu YY; Pan YS; Zhu ZG Eur J Surg Oncol; 2007 Mar; 33(2):129-32. PubMed ID: 17045774 [TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular biology of pre-malignancy in the gastrointestinal tract. Jass JR; Talbot IC Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):175-89. PubMed ID: 11355910 [TBL] [Abstract][Full Text] [Related]
10. Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects. Craanen ME; Offerhaus GJ; Tytgat GN Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):147-64. PubMed ID: 8995119 [TBL] [Abstract][Full Text] [Related]
11. [Relationship and role of morphological diagnosis and gene diagnosis of cancer (1) tumors in the gastrointestinal tract]. Kushima R Rinsho Byori; 2001 Dec; 49(12):1233-6. PubMed ID: 11797393 [TBL] [Abstract][Full Text] [Related]
12. Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract. Entius MM; Westerman AM; van Velthuysen ML; Wilson JH; Hamilton SR; Giardiello FM; Offerhaus GJ Hepatogastroenterology; 1999; 46(26):661-6. PubMed ID: 10370593 [TBL] [Abstract][Full Text] [Related]
13. [The importance of a genetic factor in digestive cancers. Hereditary cancer disposition]. Dubarry JJ Presse Med (1893); 1968 Apr; 76(17):793-6. PubMed ID: 5645334 [No Abstract] [Full Text] [Related]
14. Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer. Vogel A; Ockenga J; Ehmer U; Barut A; Kramer FJ; Tukey RH; Manns MP; Strassburg CP Z Gastroenterol; 2002 Jul; 40(7):497-502. PubMed ID: 12122597 [TBL] [Abstract][Full Text] [Related]
15. The role of heparanase in gastrointestinal cancer (Review). Naomoto Y; Takaoka M; Okawa T; Nobuhisa T; Gunduz M; Tanaka N Oncol Rep; 2005 Jul; 14(1):3-8. PubMed ID: 15944760 [TBL] [Abstract][Full Text] [Related]
16. DNA repair dysfunction in gastrointestinal tract cancers. Maehara Y; Egashira A; Oki E; Kakeji Y; Tsuzuki T Cancer Sci; 2008 Mar; 99(3):451-8. PubMed ID: 18271874 [TBL] [Abstract][Full Text] [Related]
17. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Figer A; Irmin L; Geva R; Flex D; Sulkes J; Sulkes A; Friedman E Br J Cancer; 2001 Feb; 84(4):478-81. PubMed ID: 11207041 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation. Kim YS; Deng G Gastroenterology; 2008 Jul; 135(1):305-9. PubMed ID: 18558094 [No Abstract] [Full Text] [Related]
19. Grading gastrointestinal dysplasia and what to call it when you don't know what it is. Offerhaus GJ J Pathol; 2007 Jun; 212(2):121-3. PubMed ID: 17471451 [TBL] [Abstract][Full Text] [Related]